Adenosine analogues as inhibitors of P2Y12 receptor mediated platelet aggregation
2008; Elsevier BV; Volume: 18; Issue: 6 Linguagem: Inglês
10.1016/j.bmcl.2008.01.038
ISSN1464-3405
AutoresJames G. Douglass, J. Bryan deCamp, Emilee H. Fulcher, W. Schuyler Jones, Sanjoy K. Mahanty, Anna Morgan, Dima Smirnov, José L. Boyer, Paul S. Watson,
Tópico(s)Heart Failure Treatment and Management
ResumoModified adenosine derivatives may lead to the development of P2Y(12) antagonists that are potent, selective, and bind reversibly to the receptor. Analogues of 2',3'-trans-styryl acetal-N6-ureido-adenosine monophosphate were prepared by modification of the 5'-position. The resulting analogues were tested for P2Y(12) antagonism in a platelet aggregation assay.
Referência(s)